Newsletter

009420 - Hanall Biopharma Co., Ltd.

009420 Summary
Biopharma
Stock Price & Overview
₩54,700 +800 (+1.48%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩54,700  ≈ US$39  ·  Market cap ₩2.9tn (≈ $2.0bn)
Home › 009420 › Filings

Treasury Share Disposal — Result Report

DART
Hanall Biopharma Co., Ltd.
Filed May 6, 2026 KST · Buyback · receipt 20260506000635

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 자기주식처분결과보고서

009420

Price
₩54,700
Change
+1.48%
Market cap
₩2.9tn
Prev. close
₩53,900
009420 SummaryCompare to Peers

More 009420 filings

Half-Year Report

08/14/26

Investor Relations Event

07/31/26

Preliminary Consolidated Results (Fair Disclosure)

07/29/26

Material matter affecting investment judgment ×2

07/22/26

Insider / Major Shareholder Holdings Report

07/02/26

5% Ownership Report — Short Form

07/01/26